Suchergebnisse - (Subject:"angiotensin-converting enzyme inhibitors")

PubPharm (3.631)

1

Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure

enthalten in: Journal of the American College of Cardiology | 2024

von Morrow, D. | Velazquez, E. | Desai, A. | +12

2

Concurrent exercise training potentiates the effects of angiotensin-converting enzyme inhibitor on regulatory systems of blood pressure control in ovariectomized hypertensive rats

enthalten in: Journal of hypertension | 2024

von Ferreira, M. | Dias, D. | Silva, G. | +5

3

Captopril to Lisinopril Conversion in Pediatric Cardiothoracic Surgery Patients Less Than 7 Years of Age (RISE-7)

enthalten in: Pediatric cardiology | 2024

von Bransetter, J. | Anderson, M. | Zaki, H. | +2

4

The association between ACE inhibitors and psoriasis based on the drug-targeted Mendelian randomization and real-world pharmacovigilance analyses

enthalten in: Expert review of clinical pharmacology | 2024

von Jin, Q. | Ren, F. | Song, P.

5

Influence of Age, Heart Failure and ACE Inhibitor Treatment on Plasma Renin Activity in Children : Insights from a Systematic Review and the European LENA Project

enthalten in: Frontiers in bioscience (Landmark edition) | 2023

von Steichert, M. | Cawello, W. | Bajcetic, M. | +6

CommentOn: Heart. 2021 May 26;107(12):989-995. - PMID 33712509

6

Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa : Real-World Medical Claims Database Analysis

enthalten in: Advances in therapy | 2023

von Snyman, J. | Gumedze, F. | Jones, E. | +4

7

Sex Differences in Glomerular Lesions, in Atherosclerosis Progression, and in the Response to Angiotensin-Converting Enzyme Inhibitors in the ApoE-/- Mice Model

enthalten in: International journal of molecular sciences | 2023

von Mallén, A. | Rodriguez-Urquia, R. | Alvarez, R. | +3

8

Prevalent and Incident Anemia in PARADIGM-HF and the Effect of Sacubitril/Valsartan

enthalten in: JACC. Heart failure | 2023

von Curtain, J. | Adamson, C. | Docherty, K. | +10

9

MANAGEMENT OF RISKS OF ADVERSE DRUG REACTIONS ACCORDING TO ADR REPORT FORM DATA FROM LVIV REGION HEALTHCARE FACILITIES IN 2022

enthalten in: Georgian medical news | 2023

von Stepaniuk, N. | Piniazhko, O. | Poshyvak, O. | +3

10

NITROSOGENESIS OF SKIN CANCER : THE NITROSAMINE CONTAMINATION IN THE CALCIUM CHANNEL BLOCKERS (AMLODIPINE), BETA BLOCKERS (BISOPROLOL), SARTANS (VALSARTAN/LOSARTAN), ACE INHIBITORS (PERINDOPRIL/ENALAPRIL), TRICYCLIC ANTIDEPRESSANTS (MELITRACEN), SSRIS (PAROXETINE), SNRIS (VENLAFAXINE) AND METFORMIN: THE MOST PROBABLE EXPLANATION FOR THE RISING SKIN CANCER INCIDENCE

enthalten in: Georgian medical news | 2023

von Tchernev, G.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[364]